Boston Scientific Announces Results For Third Quarter 2019
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Boston Scientific (BSX) Tops Q3 EPS by 1c, Offers Q4 Guidance
October 23, 2019 6:38 AM EDTBoston Scientific (NYSE: BSX) reported Q3 EPS of $0.39, $0.01 better than the analyst estimate of $0.38. Revenue for the quarter came in at $2.71 billion versus the consensus estimate of $2.65 billion.
GUIDANCE:
Boston Scientific sees Q4 2019 EPS of $0.42-$0.45, versus the consensus of $0.44.
The company estimates revenue growth for the full year 2019, versus the prior year period, to be in a range of approximately 9 to 9.5 percent on a reported basis (compared... More
